HORIBA, Ltd.

HORIBA, Ltd.

HRIBF
HORIBA, Ltd.US flagOther OTC
157.64
USD
- -
- -
6.62BMarket Cap
HORIBA, Ltd.
HRIBF
(Other OTC)

Recent

price

157.64

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2,803.47
2,919
2,780.55
3,265.7
3,617.79
4,080.03
4,038.2
4,635.91
4,994.31
4,747.97
4,434.02
5,315.88
6,398.45
6,875.79
7,553.14
7,934.13
7,159.9
Revenue per Share
187.45
204.85
174.86
212.75
250.28
315.22
307.73
386.27
529.22
367.07
312.57
505.04
807.04
953.71
799.44
883.5
816.14
Basic EPS, GAAP
200.93
59.68
140.48
177.33
42.62
-55.61
59.28
385.99
219.58
324.94
407.85
537.86
518.33
177.03
497.12
672.71
- -
Free Cash Flow per Basic Share
13.01
20.03
45.94
53
66.96
69.49
72.6
94.95
125.92
144.88
109.9
109.89
164.83
259.67
291.02
269.74
- -
Dividend per Share
1,666.6
1,851.07
1,979.71
2,139.25
2,321.7
2,497.7
2,732.96
3,021.57
3,423.46
3,644.43
3,845.11
4,239.71
4,879.63
5,568.89
6,041.13
6,657.34
5,609.74
Book Value per Share
1,863.01
2,029.08
2,247.06
2,587.13
2,788.04
2,775.39
2,973.98
3,474.98
3,726.48
3,937.92
4,125
4,741.28
5,619.69
6,596.72
7,359.17
8,151.19
7,081.99
Tangible Book Value per Share
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
Basic Weighted Avg Shares
118,556
123,456
117,609
138,136
153,065
171,916
170,093
195,399
210,570
200,241
187,080
224,314
270,133
290,558
317,369
333,081
302,173
Sales/Revenue/Turnover
10.38
12.07
9.99
9.94
11.25
11.72
10.88
13.73
13.7
10.45
10.53
14.29
16.97
16.28
15.23
15.92
15.91
Operating Margin (%)
4,523
4,145
3,743
4,278
4,904
6,109
6,815
7,533
7,240
8,794
9,618
10,440
11,348
12,602
13,059
13,805
- -
Depreciation Expense
7,927
8,664
7,396
8,999
10,589
13,282
12,962
16,281
22,313
15,481
13,188
21,311
34,072
40,302
33,591
37,090
34,444
Net Income, GAAP
33.29
36.51
33.79
33.85
34.9
32.93
24.81
33.16
22.75
25.2
29.93
29.44
27.92
24.95
31.19
27.35
29.09
Effective Tax Rate (%)
6.69
7.02
6.29
6.51
6.92
7.73
7.62
8.33
10.6
7.73
7.05
9.5
12.61
13.87
10.58
11.14
11.4
Profit Margin (%)
62,429
69,681
74,326
88,097
90,677
85,779
90,736
103,109
109,894
128,081
151,162
155,905
184,318
217,526
236,518
234,251
228,177
Working Capital
11,195
11,291
12,113
17,576
17,209
31,826
34,255
33,704
32,028
46,878
67,518
55,077
54,854
54,699
55,391
39,294
55,034
LT Debt
84,155
90,458
99,534
114,543
124,312
127,242
133,190
150,864
162,017
171,613
178,667
204,491
240,848
283,730
314,702
348,638
303,778
Total Equity
8.07
8.79
6.78
6.97
7.47
8.1
7.78
9.41
10.9
6.9
5.48
8.19
10.84
10.64
9.03
9.54
9.62
Return on Invested Capital (%)
9.78
9.78
7.8
8.72
9.08
10.01
8.59
9.99
12.64
7.67
5.83
8.7
12.98
14.36
11.15
11.35
12.1
Return on Capital (%)
11.87
11.65
9.13
10.33
11.22
13.06
11.76
13.43
16.42
10.39
8.35
12.49
17.7
18.26
13.73
13.91
15.17
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
5,695
8,590
11,830
LT Borrowings
54,699
54,860
55,034
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
42
42
Market Capitalization
402,476
600,680
511,986

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
318,577
316,496
327,840
Cash, Cash Equivalents & STI
134,775
127,794
136,404
Accounts Receivable, Net
71,541
69,508
69,568
Inventories
99,473
105,262
109,806
Total Current Liabilities
101,051
98,862
99,663
Payables & Accruals
- -
- -
- -
ST Debt
5,695
8,590
11,830
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.71%
14.35%
10.78%
Free Cash Flow
55.24%
35.38%
35.2%
Net Income, GAAP
14.83%
26.7%
10.42%
Sales/Revenue/Turnover
7.22%
12.41%
4.95%
Total Cash Common Dividend
- -
- -
-7.39%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70,252
72,468
- -
- -
317,369
2025
- -
- -
- -
- -
333,081
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
166.55
- -
- -
- -
799.44
2025
- -
- -
- -
- -
883.5
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
291.02
2025
- -
- -
- -
- -
269.74
2026
- -
- -
- -
- -
- -
Business
HORIBA, Ltd. designs, manufactures, and markets a broad range of instruments and systems across the globe. Its operations are structured into five key divisions: Automotive Test Systems, Process & Environmental, Medical-Diagnostic, Semiconductor Instruments & Systems, and Scientific Instruments & Systems. The Automotive Test Systems division provides advanced solutions for vehicle development, including sophisticated emission measurement systems, comprehensive engine and driveline test systems, fuel cell and battery evaluation equipment, alongside specialized engineering and consulting services for mobility. The Process & Environmental segment develops equipment to monitor and manage environmental factors and industrial processes, offering stack gas analysis, diverse water quality measurement and examination systems, air pollution monitoring devices, and environmental radiation detectors. Within the Medical-Diagnostic sphere, the company supplies in-vitro diagnostic instruments for hematology, CRP, immunology, clinical chemistry, blood glucose, and coagulation/hemostasis analysis, catering to various healthcare settings globally. The Semiconductor Instruments & Systems division delivers essential tools for semiconductor manufacturing, such as mass flow controllers, chemical concentration monitors, systems for reticle/mask particle detection, residual gas analyzers, and vaporizers, supporting the entire production lifecycle. Lastly, the Scientific Instruments & Systems segment offers a wide array of research and quality control instruments, including Raman spectrometers, pH meters, particle-size distribution analyzers, X-ray fluorescence and elemental analyzers, fluorescence spectroscopy platforms, optical components, and specialized gratings. HORIBA's cutting-edge products serve diverse applications across automotive research and development, industrial processes, environmental protection, healthcare diagnostics, semiconductor fabrication, and various scientific disciplines. Established in 1945, HORIBA, Ltd. maintains its global headquarters in Kyoto, Japan.

Company News

MCPAPIChat
  • Oasis Views HORIBA's 2026 AGM Results as Clear Warning to the Board

  • Oasis Calls on HORIBA Shareholders to Vote Against Chairman Atsushi Horiba at the 2026 Annual General Meeting

  • Contrasting Horiba (OTCMKTS:HRIBF) and JE Cleantech (NASDAQ:JCSE)

  • Horiba (OTCMKTS:HRIBF) versus Global Industrial (NYSE:GIC) Critical Analysis

  • Analyzing DMC Global (NASDAQ:BOOM) & Horiba (OTCMKTS:HRIBF)

  • Analyzing Horiba (OTCMKTS:HRIBF) & DMC Global (NASDAQ:BOOM)

  • Comparing Horiba (OTCMKTS:HRIBF) & Presidio Property Trust (NASDAQ:SQFT)

  • Financial Contrast: Kion Group (OTCMKTS:KIGRY) and Horiba (OTCMKTS:HRIBF)

  • Comparing Horiba (OTCMKTS:HRIBF) & Pressure Biosciences (OTCMKTS:PBIO)